Acceleration Strategy:

Insource Innovation

clinical_blueprint

Acceleration Strategy: Cloud Enablement and R&D IT Technology Consulting

Strategic consulting that delivers actionable plans for R&D IT and Product Development teams. With the Clinical Acceleration Strategy solution from d-wise, you obtain a strategic assessment of your clinical analysis systems and processes. Design your future Statistical Computing Environment (SCE) with our high-level strategic recommendations and accompanying, actionable blueprints.

Strategic Consultation

Read Case Study

 

Solutions Overview

With Clinical Acceleration Strategy, life science organizations gain insights and understanding of current business model pains and receive actionable road maps for improvement, including assessments, guidance and blueprints that innovate clinical analysis systems, and product development processes.

For teams and organizations seeking Statistical Programming advisory services and change management expertise, Clinical Acceleration provides the structure for modernizing clinical analysis and data science systems, integrating novel technology and optimizing business processes.

Our Clinical Acceleration Strategy solution can also mitigate or resolve many of the top challenges your team or organization may be facing, including security, data integrity or compliance risks, performance issues, misaligned systems and siloed on-premises data center.

What Makes Our Acceleration Strategy Different?

We design and prototype systems that provide frictionless access to data. With almost two decades of experience across life science R&D, IT, and business process, our consultants help organizations tackle the risks and bottlenecks that can affect their products' speed-to-market, allowing clients to focus on science.

  • Most trusted technologists and domain experts in controlled clinical development and data science
  • Independent: Vendor, software, and programming language independence maximizes value to our clients
  • Individual client based UX & UI designs and prototyping 
  • 100+ Life Science, CRO & Medical Device clients
  • 95% Top 20 Global Pharma Clinical System Modernizations

Technology Blueprint

The Technology Blueprint was designed to give sponsors an in-depth assessment of their technology, process, and human capital.  The assessment provides a future-state road map to accelerate your future vision of compliant, efficient, and submission-ready clinical analysis. Using our Market Monitor taxonomy tool we provide benchmarks that allow anonymized comparison across the industry.

Learn More

Submission Readiness Review

Identify critical gaps in the submission process months prior to submission timeliness to avoid being part of the 30% of studies that fail under the FDA technical rejection criteria. Our data team of CDISC, ADaM and standard experts review studies, and documentation from beginning to end. With a cohesive submission readiness strategy based on global regulatory guidance, d-wise has helped multiple mid-sized pharma and CROs develop the confidence that their submissions will not be rejected on a technical or conformance basis.

Learn More

Unsure whether to buy or build?

Our proven Acceleration Services are the path to customize or configure a fit-for-purpose clinical system. Discover customizable services designed to provide flexibility, performance, and scalability for organizations of any size.

Learn More

d-wise played a part in something special. With successful phase 3 results, patients with a rare disease now have a chance for a better quality of life. The analysis could not have been possible without their IT system and business process designs.Global Pharma, Data Standards Leader